What is the prevalence of Axenfeld-Rieger Syndrome?

Axenfeld-Rieger Syndrome is a rare genetic disorder with an estimated prevalence of approximately 1 in 50,000 to 1 in 100,000 individuals worldwide. Because symptoms can range from mild to severe and may go unrecognized, these figures are estimates and the true prevalence of Axenfeld-Rieger Syndrome may be higher due to underdiagnosis.

Is the prevalence of Axenfeld-Rieger Syndrome different across genders or ethnicities?

Current clinical literature indicates that Axenfeld-Rieger Syndrome affects males and females with equal frequency. There is no evidence suggesting significant geographic or ethnic variations in the prevalence of Axenfeld-Rieger Syndrome, as it is a genetic condition caused by mutations in specific genes (such as PITX2 or FOXC1) that appear across diverse global populations.

What are the primary challenges in estimating the number of cases?

Accurately calculating the number of people living with Axenfeld-Rieger Syndrome is difficult because of the following factors:

• Phenotypic Variability: Some individuals may have very mild ocular features that do not prompt a clinical evaluation.


• Diagnostic Complexity: Axenfeld-Rieger Syndrome is often misdiagnosed as isolated glaucoma or other anterior segment dysgenesis conditions.


• Underreporting: Many patients with mild systemic features may never receive a formal genetic diagnosis.

What is the typical age of onset for Axenfeld-Rieger Syndrome?

Axenfeld-Rieger Syndrome is a congenital condition, meaning it is present at birth. While the ocular manifestations—such as glaucoma—often appear during childhood or adolescence, some patients may not be diagnosed until adulthood when secondary complications arise. Within the DiseaseMaps.org community, 20 people with Axenfeld-Rieger Syndrome have shared their lived experiences, highlighting the diverse age ranges at which members receive their formal diagnosis.

How is the rarity of this condition classified?

Axenfeld-Rieger Syndrome is classified as a rare disease. In the context of global health, conditions affecting fewer than 1 in 2,000 people are typically considered rare. While Axenfeld-Rieger Syndrome is not considered "ultra-rare," the limited number of documented cases makes it challenging for general practitioners to recognize, often requiring referral to specialized ophthalmology or genetic centers.

Next steps

• Consult with a genetic counselor to discuss family testing if Axenfeld-Rieger Syndrome is suspected.


• Schedule regular screenings with an ophthalmologist specializing in glaucoma to monitor intraocular pressure.


• Connect with the 20 members of the DiseaseMaps.org community to share experiences and coping strategies.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Axenfeld-Rieger Syndrome.


• Orphanet: Axenfeld-Rieger syndrome (ORPHA:93529).


• OMIM (Online Mendelian Inheritance in Man): Axenfeld-Rieger Syndrome 1 (Entry #180500).


• National Eye Institute (NEI): Research on Anterior Segment Dysgenesis.